Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Optimization and individualization of thiopurine therapy in inflammatory bowel disease: the great variability among drug responses.

The pharmacogenomics journal - 1 Jan 2003

Scherl E, Subbaramiah K

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Immunosuppressive Agents
Share to Inflammatory Bowel Diseases
Share to Mercaptopurine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Methyltransferases

Share to Phenotype

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 12746731
DOI: 10.1038/sj.tpj.6500162

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Optimization and individualization of thiopurine therapy in inflammatory bowel disease: the great variability among drug responses.PMID 12746731Read ↗

Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy?Semantic proximity Read ↗

Thiopurine Therapy in Patients With Inflammatory Bowel Disease: A Focus on Metabolism and PharmacogeneticsSemantic proximity Read ↗

Personalization of thiopurine therapy: Current recommendations and future perspectives.Semantic proximity Read ↗

Pharmacogenetics of Inflammatory Bowel DiseaseSemantic proximity Read ↗

Pharmacogenetics of treatments for inflammatory bowel diseaseSemantic proximity Read ↗

Genotype-based Treatment With Thiopurine Reduces Incidence of Myelosuppression in Patients With Inflammatory Bowel DiseasesSemantic proximity Read ↗

Role of Pharmacogenomics in the Efficacy and Safety of Thiopurines in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.Semantic proximity Read ↗

Personalizing therapy selection in inflammatory bowel disease.Semantic proximity Read ↗

Therapeutic drug monitoring in patients with inflammatory bowel disease.Semantic proximity Read ↗

On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance.Semantic proximity Read ↗

Pharmacogenetics of therapies in rheumatoid arthritis: An update.Semantic proximity Read ↗

Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug MonitoringSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.